日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Targeting FAM111B attenuates mitophagy and increases the sensitivity to lenvatinib treatment by increasing MFN2 stability in hepatocellular carcinoma

靶向FAM111B可通过增加MFN2在肝细胞癌中的稳定性来减弱线粒体自噬并提高其对乐伐替尼治疗的敏感性。

期刊:Cell Death & Disease
影响因子:9.6
doi:10.1038/s41419-025-07941-1
Yan, Yu-Chuan; Shao, Li-Juan; Meng, Guang-Xiao; Pan, Guo-Qiang; Li, Rui-Zhe; Xiong, Chen; Liu, Shi-Jia; Ding, Zi-Niu; Zhang, Xiao-Lu; Dong, Xiao-Feng; Qu, Ying; Dong, Zhao-Ru; Li, Tao
肿瘤
肿瘤免疫
MFN2
线粒体
细胞生物学
自噬
发表日期：2025
文献求助 收藏

(18)F-FDG PET/CT Predicts the Prognosis of Patients with Hepatocellular Carcinoma Undergoing Liver Transplantation.

（18）F-FDG PET/CT 预测接受肝移植的肝细胞癌患者的预后

期刊:Liver Cancer
影响因子:9.1
doi:10.1159/000544966
Zheng Wen-Jing, Xu Yang, Tan Hui, Chen Shu-Guang, Wang Peng-Xiang, Sun Hai-Xiang, Li Rui-Zhe, Zeng Hai-Ying, Zhong Yu-Chen, Cheng Jian-Wen, Fan Jia, Zhou Jian, Shi Hongcheng, Yang Xin-Rong
细胞生物学
发表日期：2025
文献求助 收藏

Thyroid hormones inhibit tumor progression and enhance the antitumor activity of lenvatinib in hepatocellular carcinoma via reprogramming glucose metabolism.

甲状腺激素通过重编程葡萄糖代谢抑制肿瘤进展，增强乐伐替尼在肝细胞癌中的抗肿瘤活性

期刊:Cell Death Discovery
影响因子:7
doi:10.1038/s41420-025-02378-z
Yang Chun-Cheng, Yan Yu-Chuan, Pan Guo-Qiang, Meng Guang-Xiao, Zhang Xiao, Yan Lun-Jie, Ding Zi-Niu, Wang Dong-Xu, Li Rui-Zhe, Li Guang-Zhen, Dong Zhao-Ru, Li Tao
代谢
肿瘤
发表日期：2025
文献求助 收藏

Mutation status of the KMT2 family associated with immune checkpoint inhibitors (ICIs) therapy and implicating diverse tumor microenvironments

KMT2家族的突变状态与免疫检查点抑制剂（ICIs）疗法相关，并涉及多种肿瘤微环境

期刊:Molecular Cancer
影响因子:33.9
doi:10.1186/s12943-023-01930-8
Wang, Dong-Xu; Long, Jun-Yu; Li, Rui-Zhe; Zhang, Dao-Lin; Liu, Hui; Liu, Jingru; Tian, Jin-Cheng; Li, Han; Liu, Jie; Zhao, Hai-Tao; Li, Tao
肿瘤
肿瘤微环境
肿瘤免疫
免疫/内分泌
发表日期：2024
文献求助 收藏

Correction: MALAT1/ mir-1-3p mediated BRF2 expression promotes HCC progression via inhibiting the LKB1/AMPK signaling pathway

更正：MALAT1/mir-1-3p介导的BRF2表达通过抑制LKB1/AMPK信号通路促进HCC进展

期刊:Cancer Cell International
影响因子:6
doi:10.1186/s12935-024-03399-x
Li, Guang-Zhen; Meng, Guang-Xiao; Pan, Guo-Qiang; Zhang, Xiao; Yan, Lun-Jie; Li, Rui-Zhe; Ding, Zi-Niu; Tan, Si-Yu; Wang, Dong-Xu; Tian, Bao-Wen; Yan, Yu-Chuan; Dong, Zhao-Ru; Hong, Jian-Guo; Li, Tao
信号转导
AMPK
LAT
LAT1
发表日期：2024
文献求助 收藏

MALAT1/ mir-1-3p mediated BRF2 expression promotes HCC progression via inhibiting the LKB1/AMPK signaling pathway

MALAT1/mir-1-3p介导的BRF2表达通过抑制LKB1/AMPK信号通路促进肝细胞癌进展。

期刊:Cancer Cell International
影响因子:6
doi:10.1186/s12935-023-03034-1
Li, Guang-Zhen; Meng, Guang-Xiao; Pan, Guo-Qiang; Zhang, Xiao; Yan, Lun-Jie; Li, Rui-Zhe; Ding, Zi-Niu; Tan, Si-Yu; Wang, Dong-Xu; Tian, Bao-Wen; Yan, Yu-Chuan; Dong, Zhao-Ru; Hong, Jian-Guo; Li, Tao
肿瘤
肿瘤免疫
信号转导
AMPK
LAT
LAT1
细胞生物学
发表日期：2023
文献求助 收藏

Dimethyl 3,3'-[(4-nitro-phen-yl)methyl-ene]bis-(1H-indole-2-carboxyl-ate) ethanol hemisolvate

3,3'-[(4-硝基苯基)亚甲基]双-(1H-吲哚-2-羧酸酯)乙醇半溶剂化物

期刊:IUCrdata
影响因子:
doi:10.1107/S2414314621000572
Li, Yu-Long; Zhou, Jin; Jiang, Hong; Sun, Hong-Shun; Li, Rui-Zhe; Liu, Sha-Li; Zhang, Xu-Dong
发表日期：2021
文献求助 收藏